CORONA Remedies Limited has informed the Exchange about Schedule of meet
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CORONA Remedies Limited has notified the stock exchanges about a Q4 FY26 earnings conference call scheduled for May 12, 2026 at 11:00 AM IST. The call will discuss the company's financial results for the fourth quarter and year ended March 31, 2026. Key company representatives including Managing Director & CEO Mr. Nirav Mehta, Joint Managing Director Mr. Ankur Mehta, and CFO Mr. Bhavin Bhagat will participate in the call. The conference is being hosted by institutional equities firm Ambit Capital and shareholders can join via telephone dial-in numbers provided.
This is a routine regulatory disclosure allowing retail and institutional investors to participate in an earnings discussion with company management. Such calls typically provide insights into quarterly performance and future outlook, which may be material for shareholder decisions.